Stroke Trial, Recruiting NCT06753006 Sponsor: Neurotechnika Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06753006
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 80 years old at the time their stroke occurred.
  • People who have had a stroke confirmed by an MRI or CT scan.
  • People who are within 6 months of having their stroke (early recovery period).
  • People who have some weakness in one or both arms, rated between 0 and 3 on a standard 6-point muscle strength scale.
  • People who are able and willing to follow the study's procedures and schedule.
  • People who have shown genuine motivation to participate in rehabilitation.
  • People who have read and signed a consent form agreeing to take part.

Who may not be able to join:

  • People with significant thinking or memory difficulties, based on a standard cognitive test score below 10 (confirm with trial site).
  • People with moderate to severe depression, based on a standard depression rating scale score above 18 (confirm with trial site).
  • People with very severe stroke-related disability, based on a standard disability scale score above 4 (confirm with trial site).
  • People who had arm weakness or stiffness before their stroke due to conditions such as cerebral palsy, traumatic brain injury, Parkinson's disease, or joint contractures.
  • People with severe arthritis or significantly limited movement in their arms.
  • People who have had any part of an arm amputated.
  • People with any medical condition that could affect their safety or the running of the study, such as a serious mental illness.
  • People who have used alcohol heavily or taken recreational drugs in the 12 months before the study.
  • People who have used an experimental medication or medical device in the 30 days before the study.
  • People whose overall neurological or physical condition is too severe to allow full participation in rehabilitation.
  • People with very poor vision, specifically below 0.2 in their weaker eye on a standard vision chart (confirm with trial site).
  • People who have had unstable chest pain (angina) or a heart attack in the 30 days before the study.
  • People who have had more than one stroke.
  • People with high blood pressure that is not controlled by treatment.
  • People with ataxia, a condition affecting balance and coordination.
  • People who have a pacemaker or any other implanted electronic device.
  • People who are currently using muscle relaxant medications.
  • People with peripheral neuropathy, a condition involving nerve damage in the limbs.
  • People with another serious illness that is currently active or unstable and requires treatment.
  • People who have skin irritation, allergic reactions, or skin sores in the areas where EEG electrodes (brain-monitoring sensors) would be placed on the scalp.
  • People with an active urinary tract infection.
  • People with acute thrombophlebitis, which is inflammation of a vein combined with a blood clot.
  • People with any form of epilepsy.
  • People with any type of benign or malignant tumour.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alexander Zakharov, Ph.D., Samara State Medical University

Phone: +79272081176

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Neurotechnika
Registry
ClinicalTrials.gov
Start date
27 August 2024
Est. completion
1 July 2025

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

FMA-UE A-D; ARAT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov